Case Study

Large Global Phase III Clinical Trial In Metastatic Colorectal Carcinoma (mCRC)

Can Big Data Rescue Clinical Trials

UBC successfully managed a large global phase III clinical trial in patients with mCRC refractory to standard chemotherapies. The target was to randomize 800 patients in an 18-month period. The trial ran in 113 sites, across 13 countries. This was a full service contract, with UBC being responsible for all activities related to study execution and analysis. Read how UBC successfully completed patient enrollment 3 months ahead of schedule and database lock 3.5 months ahead of schedule.

VIEW THE CASE STUDY!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Clinical Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: